News

SARS-CoV-2 banner image
March 31, 2020
Language flag
New CEO commentary: “Bridging Corona”
As the dust from the stampede of bewildered politicians and overconfident billionaires settles, we begin to discern the new world shaped by the COVID-19 pandemic.
Cell Banner
March 12, 2020
Language flag
Interim Report 3 2019/20
With permanent staff on the ground in the US, we will be able to prepare, train and support a US sales organization much more efficiently than what was previously achievable.
Gladstone Institutes Building
March 10, 2020
Language flag
Gladstone Institutes, University of California and PHI form joint Center of Excellence
Gladstone Institutes, University of California in San Francisco and PHI recently formed San Francisco’s Center of Excellence for Holographic Imaging Cytometry.
Women working in a cell laboratory
March 2, 2020
Language flag
New CEO commentary: “Joining forces with Huntsman”
PHI recently joined forces with the Huntsman Cancer Institute in the battle against cancer.
HoloMonitor M4 with logo
January 7, 2020
Language flag
CEO interview in BioStock
In the article published today by BioStock, the company's CEO Peter Egelberg comments on the developments during the past autumn.
Single-cell analysis using supercomputers
January 2, 2020
Language flag
New CEO commentary: “The Single-Cell Revolution”
PHI’s CEO and founder Peter Egelberg comments the recently published innovation report from the UN agency World Intellectual Property Organization.

In Swedish

May 23, 2019
Language flag
Idag inleds inlösenperioden av teckningsoptioner av serie TO 2
Idag, den 23 maj 2019, inleds inlösenperioden av de teckningsoptioner av serie TO 2 som emitterades i samband med Phase Holographic Imaging PHI AB:s (”PHI”) företrädesemission av units under sommaren 2018.
December 6, 2018
Language flag
Lunds Universitet och PHI samarbetar kring utveckling av nya 3D-cellodlingsmetoder för immunterapiforskning
Baserat på PHI:s befintliga HoloMonitor-teknik, har institutionen för Immun­teknologi vid Lunds Universitet och Phase Holographic Imaging (PHI) avtalat om att gemensamt utveckla nya metoder för 3‑dimensionell cell­odling. Detta för att möta ett akut och snabbt växande behov av dessa metoder inom cancerforskningen.
March 20, 2017
Language flag
PHI and Malmö University receives 2.3 million SEK to detect blood-borne cancer cells
GlycoImaging is a collaboration project between PHI, Malmö University and four international research institutions. By combining PHI’s HoloMonitor technology with a new type of cancer probes, more sensitive methods to detect and diagnose cancer at an earlier stage than what is possible today.